1. Home
  2. ABEO vs PMM Comparison

ABEO vs PMM Comparison

Compare ABEO & PMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABEO
  • PMM
  • Stock Information
  • Founded
  • ABEO 1974
  • PMM 1989
  • Country
  • ABEO United States
  • PMM United States
  • Employees
  • ABEO N/A
  • PMM N/A
  • Industry
  • ABEO Biotechnology: Pharmaceutical Preparations
  • PMM Investment Managers
  • Sector
  • ABEO Health Care
  • PMM Finance
  • Exchange
  • ABEO Nasdaq
  • PMM Nasdaq
  • Market Cap
  • ABEO 256.9M
  • PMM 265.3M
  • IPO Year
  • ABEO 1980
  • PMM N/A
  • Fundamental
  • Price
  • ABEO $5.93
  • PMM $5.87
  • Analyst Decision
  • ABEO Strong Buy
  • PMM
  • Analyst Count
  • ABEO 6
  • PMM 0
  • Target Price
  • ABEO $18.00
  • PMM N/A
  • AVG Volume (30 Days)
  • ABEO 870.0K
  • PMM 118.3K
  • Earning Date
  • ABEO 08-11-2025
  • PMM 01-01-0001
  • Dividend Yield
  • ABEO N/A
  • PMM 4.68%
  • EPS Growth
  • ABEO N/A
  • PMM N/A
  • EPS
  • ABEO N/A
  • PMM 0.23
  • Revenue
  • ABEO N/A
  • PMM N/A
  • Revenue This Year
  • ABEO N/A
  • PMM N/A
  • Revenue Next Year
  • ABEO $323.51
  • PMM N/A
  • P/E Ratio
  • ABEO N/A
  • PMM $26.52
  • Revenue Growth
  • ABEO N/A
  • PMM N/A
  • 52 Week Low
  • ABEO $3.93
  • PMM $5.00
  • 52 Week High
  • ABEO $7.32
  • PMM $6.42
  • Technical
  • Relative Strength Index (RSI)
  • ABEO 45.53
  • PMM 45.89
  • Support Level
  • ABEO $6.10
  • PMM $5.82
  • Resistance Level
  • ABEO $6.24
  • PMM $5.93
  • Average True Range (ATR)
  • ABEO 0.29
  • PMM 0.04
  • MACD
  • ABEO -0.09
  • PMM 0.00
  • Stochastic Oscillator
  • ABEO 4.26
  • PMM 41.67

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

About PMM Putnam Managed Municipal Income Trust

Putnam Managed Municipal Income Trust is a closed-end management investment company. Its investment objective is to seek a high level of current income exempt from federal income tax by investing in a diversified portfolio of tax-exempt municipal securities. The Fund invests in various sectors such as healthcare, retirement community, private higher education, housing-backed, essential service utilities, and state-backed bonds.

Share on Social Networks: